Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lennox-Gastaut syndrome
Biotech
Takeda takes $140M loss on failed epilepsy drug, touts FDA run
A clinical failure of epilepsy medicine soticlestat will cost Takeda $140 million, even as the company plans to take it to regulators anyway.
Annalee Armstrong
Jul 31, 2024 9:14am
Takeda flunks pivotal epilepsy tests but mulls path to market
Jun 17, 2024 8:50am
Longboard’s shares triple as epilepsy med halves seizure rates
Jan 2, 2024 10:49am
